it's about being professional and respecting the materials
Recalls & Warnings May 01, 2023 TruVision Recalls Products Due to Presence of Potentially Dangerous Ingredients On April 27, 2023, TruVision Health issued a recall of various dietary supplement products because they contain hordenine and/or octodrine/DMHA, compounds that the FDA considers to be possibly unsafe and which are not permitted to be sold as dietary supplements
These effects contribute to the preservation of cognitive function in models of I/R injury (Dong and Mayer, 2024)
New research published today in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonistsdrugs commonly used to treat obesity and diabetesand better outcomes among breast cancer patients
The Trump administration also announced in April 2025 that it does not intend to approve new or extend existing requests for federal matching funds for state expenditures for DSHP
And hopefully I can help relieve some of that burden in how we talk about all of this